Amgen Inc (HKSE:04332)
HK$ 1761 0 (0%) Market Cap: 1.17 Til Enterprise Value: 1.57 Til PE Ratio: 35.86 PB Ratio: 20.00 GF Score: 92/100

Amgen Inc at Bank of America Global Healthcare Conference Transcript

May 09, 2023 / 03:00PM GMT
Release Date Price: HK$1850
Daniel Lundquist

And thank you for coming out to Las Vegas for the 2023 Healthcare Conference. You are at the first session with Amgen. I'm very pleased today to be joined by Peter Griffith, the CFO; and Dave Reese, Executive VP of R&D, here on stage today.

We do have a couple of prepared remarks from Peter and plenty of time for Q&A. We can go to the crowd for those that have any questions. I'm Dan Lundquist, the BofA health care specialist. So I'm very excited today to kick off the conference. And with that, let me hand it over to Peter.

Peter H. Griffith
Amgen Inc. - Executive VP & CFO

Dan, thank you very, very much. Good morning, everyone. Great to see all of you. And thank you very much, Bank of America, for hosting us. We're just delighted to be here.

Let's start where we always do at Amgen, and that's with patients. So our mission at Amgen is to discover, develop, manufacture and deliver first-in-class and best-in-class medicines to patients with serious and grievous illnesses all over the world.

And having said that,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot